reports
The Lovesac Company Reports Third Quarter Fiscal 2026 Financial Result...
The Lovesac Company Reports Third Quarter Fiscal 2026 Financial Results Q3 FY26 Net Sales Increased 0.2% to $150.2 Million vs. Q3 FY25 STAMFORD, Conn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced financial results for the third quarter of fiscal 2026, which ended November 2, 2025. Shawn Nelson, Chief Executive Officer, stated, “Our focus on secular growth initiatives such as new products and the beginni...
Genelux Corporation to Participate in a Fireside Chat at Piper Sandler...
Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference WESTLAKE VILLAGE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board and Matt Pulisic, Chief Financial Officer, will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 12:00 p.m. ET in New York, NY. A live webcast of the fireside chat can be found . Following the live webcast, an archiv...
The Lovesac Company Announces Third Quarter Conference Call Date
The Lovesac Company Announces Third Quarter Conference Call Date STAMFORD, Conn., Nov. 26, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand, today announced that its third quarter financial results will be released before market open on Thursday, December 11, 2025. The Company will host a conference call at 8:30 a.m. Eastern Time to discuss the financial results. Investors and analysts interested in participating in the call are invited to dial 877-407-3982 (international callers please dial 201-493-...
The Lovesac Company Appoints Wan Ling Martello to Its Board of Directo...
The Lovesac Company Appoints Wan Ling Martello to Its Board of Directors STAMFORD, Conn., Nov. 20, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced that Wan Ling Martello has been appointed to the Board of Directors, effective November 20, 2025. Andrew Heyer, Chairman of the Board of Directors, stated, “We are delighted to welcome Wan Ling to our Board of Directors. Her exceptional track record of driving transformationa...
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of BlackRock MuniYield Pennsylvania Quality Fund and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 17 November 2025 in which we reassessed the appropriateness o...
- Jan Frederik Slijkerman
- Jeroen van den Broek
- Jesse Norcross
- Nadège Tillier
- Timothy Rahill
Coffee, Croissants & Credit/EnBW, Enel, Verizon, Merlin Properties, Co...
Utilities: EnBW 9M25 financial performance slightly down. Enel 9M25 financials in line with expectations. Telecom: Verizon reportedly preparing job cuts. Real Estate: Merlin Properties 9M25: Good results with a strong Madrid office market. Colonial 9M25: Solid results, prime CBD office exposure continues to perform well
Genelux Corporation Reports Third Quarter 2025 Financial Results and P...
Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates -- Lung cancer programs progressing with interim data updates expected in Q4 2025 -- -- Topline data from OnPrime Phase 3 ovarian cancer registrational trial expected in the second half of 2026 -- -- Cash, cash equivalents, short-term investments and restricted cash of $21.0 million as of September 30, 2025 -- WESTLAKE VILLAGE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the third...
The Lovesac Company Appoints Jacob Pat as Chief Technology and Digital...
The Lovesac Company Appoints Jacob Pat as Chief Technology and Digital Transformation Officer Proven Technology Leader to Enhance the Company’s Digital Strategies to Support Growth Objectives STAMFORD, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced the appointment of Jacob Pat as Chief Technology and Digital Transformation Officer effective immediately. Mr. Pat will spearhead Lovesac’s enterprise techn...
The Lovesac Company Announces Participation in Upcoming Investor Confe...
The Lovesac Company Announces Participation in Upcoming Investor Conference STAMFORD, Conn., Oct. 01, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, announced today that the Company is scheduled to participate in the 2025 Global Consumer & Retail Conference hosted by Telsey Advisory Group in collaboration with Santander Corporate & Investment Banking on Wednesday, October 8, 2025, at 3:30 p.m. Eastern Time. The fireside chat will be w...
The Lovesac Company Reports Second Quarter Fiscal 2026 Financial Resul...
The Lovesac Company Reports Second Quarter Fiscal 2026 Financial Results Q2 FY26 Net Sales Increased 2.5% to $160.5 Million vs. Q2 FY25 STAMFORD, Conn., Sept. 11, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced financial results for the second quarter of fiscal 2026, which ended August 3, 2025. Shawn Nelson, Chief Executive Officer, stated, “We're pleased to have delivered another quarter of market share gains under...
Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwrig...
Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference WESTLAKE VILLAGE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that , President, CEO and Chairman of the Board and , Chief Financial Officer, will participate in a fireside chat at H.C. Wainwright & Co’s Annual Global Investment Conference on Tuesday, September 9, 2025. Biotech Equity Research Analyst, Emily Bodnar, will moderate the session which is scheduled to begin at 2:30 p.m. ET. To register for and view ...
The Lovesac Company Announces Second Quarter Conference Call Date
The Lovesac Company Announces Second Quarter Conference Call Date STAMFORD, Conn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand, today announced that its second quarter financial results will be released before market open on Thursday, September 11, 2025. The Company will host a conference call at 8:30 a.m. Eastern Time to discuss the financial results. Investors and analysts interested in participating in the call are invited to dial 877-407-3982 (international callers please dial 201-4...
The Lovesac Company Appoints Alan Boehme to Its Board of Directors
The Lovesac Company Appoints Alan Boehme to Its Board of Directors STAMFORD, Conn., Aug. 27, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) ("Lovesac" or the "Company"), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced that Alan Boehme has been appointed to the Board of Directors, effective August 27, 2025. Andrew Heyer, Chairman of the Board of Directors, stated, "We are thrilled to welcome Alan to our Board. His exceptional track record of driving digital transformation, operational excellence,...
Genelux Corporation Reports Second Quarter 2025 Financial Results and ...
Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates WESTLAKE VILLAGE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the second quarter of 2025 and provided general business updates. Momentum continued to build across the Company, as it looks forward to a series of key clinical readouts over the next year. These readouts are intended to further demonstrate the ability of Olvi-Vec to resensitize tumors to frontline platinum-based regimens. G...
Genelux Corporation Announces Appointment of Eric Groen as General Cou...
Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development WESTLAKE VILLAGE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced the appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development, effective July 1, 2025. "We are delighted to welcome Eric to the executive team,” said Thomas Zindrick, President, CEO, and Chairman of the Board. “Eric brings a power...
The Lovesac Company issues Notice of Settlement of Shareholder Derivat...
The Lovesac Company issues Notice of Settlement of Shareholder Derivative Actions STAMFORD, Conn., June 13, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand, today released the following notice: A Federal Court authorized this Notice. This is not a solicitation from a lawyer. TO:ALL PERSONS OR ENTITIES WHO HOLD OR BENEFICIALLY OWN COMMON STOCK OF THE LOVESAC COMPANY AS OF MAY 19, 2025 (“SECURITIES HOLDERS”). PLEASE READ THIS NOTICE CAREFULLY AND COMPLETELY BECAUSE YOUR RIGHTS MIGHT BE AFFECTED BY T...
The Lovesac Company Reports First Quarter Fiscal 2026 Financial Result...
The Lovesac Company Reports First Quarter Fiscal 2026 Financial Results Q1 FY26 Net Sales Increased 4.3% to $138.4 Million vs. Q1 FY25 STAMFORD, Conn., June 12, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced financial results for the first quarter of fiscal 2026, which ended May 4, 2025. Shawn Nelson, Chief Executive Officer, stated, “Our first quarter performance was inline with our expectations to capitalize on sec...
The Lovesac Company Announces First Quarter Conference Call Date
The Lovesac Company Announces First Quarter Conference Call Date STAMFORD, Conn., May 29, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand, today announced that its first quarter financial results will be released before market open on Thursday, June 12, 2025. The Company will host a conference call at 8:30 a.m. Eastern Time to discuss the financial results. Investors and analysts interested in participating in the call are invited to dial 877-407-3982 (international callers please dial 201-493-678...
Genelux Corporation Reports First Quarter 2025 Financial Results and P...
Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates WESTLAKE VILLAGE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the first quarter of 2025 and provided general business updates. “The first quarter of 2025 has been highly productive and sets a strong foundation for the year ahead. We are well positioned to advance Olvi-Vec across multiple high-need cancer indications, with encouraging regulatory feedback from the FDA on our OnPrime Phase ...
Genelux Corporation to Participate in a Fireside Chat at the Citizens ...
Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference WESTLAKE VILLAGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that , President, CEO and Chairman of the Board, and , CFO, will discuss clinical-stage programs and upcoming milestones in a fireside chat at the Citizens Life Sciences Conference taking place May 7-8, 2025, in New York. The conversation with Biotech Equity Research Managing Director, Silvan Tuerkcan, PhD, is scheduled to begin at 1:30 p.m. ET on Thursd...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.